董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Joseph A. Carlucci | 男 | Chief Executive Officer and Chairman of the Board | 66 | 105.88万美元 | 未持股 | 2020-03-20 |
| Syed T. Kamal | 男 | President and Director | 67 | 94.71万美元 | 未持股 | 2020-03-20 |
| Steven M. Silver | 男 | independent director | 51 | 未披露 | 未持股 | 2020-03-20 |
| Jared S. Hendricks | 男 | independent director | 39 | 未披露 | 未持股 | 2020-03-20 |
| Susanne V. Clark | 女 | independent director | 51 | 未披露 | 未持股 | 2020-03-20 |
| Thomas W. Erickson | 男 | director | 69 | 167.00万美元 | 未持股 | 2020-03-20 |
| Michael E. Boxer | 男 | independent director | 58 | 21.19万美元 | 未持股 | 2020-03-20 |
| John M. Jureller | 男 | independent director | 60 | 45.50万美元 | 未持股 | 2020-03-20 |
| Robert H. Fish | 男 | independent director | 69 | 19.76万美元 | 未持股 | 2020-03-20 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Joseph A. Carlucci | 男 | Chief Executive Officer and Chairman of the Board | 66 | 105.88万美元 | 未持股 | 2020-03-20 |
| Syed T. Kamal | 男 | President and Director | 67 | 94.71万美元 | 未持股 | 2020-03-20 |
| Don E. Williamson | 男 | Executive Vice President and Chief Operating Officer | 57 | 177.21万美元 | 未持股 | 2020-03-20 |
| Mark C. Herbers | 男 | Interim Chief Financial Officer and Interim Chief Accounting Officer | 65 | 未披露 | 未持股 | 2020-03-20 |
董事简历
中英对照 | 中文 | 英文- Joseph A. Carlucci
-
Joseph A. Carlucci是American Renal Associates Holdings, Inc.的联合创始人，自2005年起担任首席执行官，并自2012年起担任Shlomo Kramer。Carlucci先生在透析服务行业拥有40多年的经验。Carlucci先生还在American Renal Associates Holdings, Inc.于1999年至2005年成立期间担任American Renal Associates Holdings, Inc.的首席运营官和财务主管。在共同创立American Renal Associates Holdings, Inc.之前，Carlucci先生曾担任Optimal Renal Care的总裁兼首席执行官，Optimal Renal Care是FMCNA和南加州Kaiser Permanente的合资企业，旨在作为一家疾病管理组织，提供更多机会来改善治疗效果，改善成本结构并实施透析护理的新技术和方法。在此之前，Carlucci先生曾担任FMCNA的行政副总裁，负责全国范围内的管理式护理、医疗总监关系和设施开发。他拥有从设施管理员到FMCNA美国运营总监的运营经验。Carlucci先生还在科罗拉多生殖医学中心的董事会任职。Carlucci先生拥有学士学位，本特利大学会计学博士。
Joseph A. Carlucci is a co-founder of American Renal Associates Holdings, Inc. and has served as Chief Executive Officer since 2005 and as Chairman of the Board since 2012. Mr. Carlucci has more than 40 years of experience in the dialysis services industry. Mr. Carlucci also served as American Renal Associates Holdings, Inc. Chief Operating Officer and Treasurer from American Renal Associates Holdings, Inc. inception in 1999 to 2005. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Carlucci served as President and Chief Executive Officer of Optimal Renal Care, a joint venture between FMCNA and Kaiser Permanente of Southern California designed as a disease management organization providing additional opportunities to improve treatment outcomes, improve cost structures and implement new technologies and methods of dialysis care. Prior to that, Mr. Carlucci served as Vice President of Administration at FMCNA and was responsible nationally for managed care, medical director relations and facility development. He has operations experience from Facility Administrator to Director of U.S. Operations at FMCNA. Mr. Carlucci also serves on the board of directors of the Colorado Center for Reproductive Medicine. Mr. Carlucci holds a B.S. in Accounting from Bentley University. - Joseph A. Carlucci是American Renal Associates Holdings, Inc.的联合创始人，自2005年起担任首席执行官，并自2012年起担任Shlomo Kramer。Carlucci先生在透析服务行业拥有40多年的经验。Carlucci先生还在American Renal Associates Holdings, Inc.于1999年至2005年成立期间担任American Renal Associates Holdings, Inc.的首席运营官和财务主管。在共同创立American Renal Associates Holdings, Inc.之前，Carlucci先生曾担任Optimal Renal Care的总裁兼首席执行官，Optimal Renal Care是FMCNA和南加州Kaiser Permanente的合资企业，旨在作为一家疾病管理组织，提供更多机会来改善治疗效果，改善成本结构并实施透析护理的新技术和方法。在此之前，Carlucci先生曾担任FMCNA的行政副总裁，负责全国范围内的管理式护理、医疗总监关系和设施开发。他拥有从设施管理员到FMCNA美国运营总监的运营经验。Carlucci先生还在科罗拉多生殖医学中心的董事会任职。Carlucci先生拥有学士学位，本特利大学会计学博士。
- Joseph A. Carlucci is a co-founder of American Renal Associates Holdings, Inc. and has served as Chief Executive Officer since 2005 and as Chairman of the Board since 2012. Mr. Carlucci has more than 40 years of experience in the dialysis services industry. Mr. Carlucci also served as American Renal Associates Holdings, Inc. Chief Operating Officer and Treasurer from American Renal Associates Holdings, Inc. inception in 1999 to 2005. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Carlucci served as President and Chief Executive Officer of Optimal Renal Care, a joint venture between FMCNA and Kaiser Permanente of Southern California designed as a disease management organization providing additional opportunities to improve treatment outcomes, improve cost structures and implement new technologies and methods of dialysis care. Prior to that, Mr. Carlucci served as Vice President of Administration at FMCNA and was responsible nationally for managed care, medical director relations and facility development. He has operations experience from Facility Administrator to Director of U.S. Operations at FMCNA. Mr. Carlucci also serves on the board of directors of the Colorado Center for Reproductive Medicine. Mr. Carlucci holds a B.S. in Accounting from Bentley University.
- Syed T. Kamal
-
Syed T. Kamal是American Renal联合控股公司的联合创始人，自1999年American Renal联合控股公司成立以来一直担任总裁和董事。Kamal先生还在1999年至2005年期间担任执行副总裁。Kamal先生在透析服务行业拥有近40年的经验。在共同创立American Renal Associates Holdings, Inc.之前，Kamal先生曾在费森尤斯医疗北美“FMCNA”担任过各种管理职务，包括FMCNA南部业务部总裁、FMCNA北美分部运营副总裁、FMNCA国际部运营总监兼副总裁，FMNCA中大西洋和东南部地区（美国）区域经理。Kamal先生拥有学士学位。巴基斯坦旁遮普大学经济学和统计学学士以及工商管理硕士学位。
Syed T. Kamal is a co-founder of American Renal Associates Holdings, Inc. company and has served President and a director since American Renal Associates Holdings, Inc. inception in 1999. Mr. Kamal also served as Executive Vice President from 1999 to 2005. Mr. Kamal has nearly 40 years of experience in the dialysis services industry. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Kamal served in various management roles at Fresenius Medical Care North America "FMCNA", including as President of FMCNA's southern business unit, Vice President of Operations for FMCNA's North America division, Director and Vice President of Operations for FMNCA's International division and Regional Manager of FMNCA's Mid Atlantic and Southeast regions (U.S.). Mr. Kamal holds a B.A. in Economics and Statistics and an M.B.A. from the University of Punjab in Pakistan. - Syed T. Kamal是American Renal联合控股公司的联合创始人，自1999年American Renal联合控股公司成立以来一直担任总裁和董事。Kamal先生还在1999年至2005年期间担任执行副总裁。Kamal先生在透析服务行业拥有近40年的经验。在共同创立American Renal Associates Holdings, Inc.之前，Kamal先生曾在费森尤斯医疗北美“FMCNA”担任过各种管理职务，包括FMCNA南部业务部总裁、FMCNA北美分部运营副总裁、FMNCA国际部运营总监兼副总裁，FMNCA中大西洋和东南部地区（美国）区域经理。Kamal先生拥有学士学位。巴基斯坦旁遮普大学经济学和统计学学士以及工商管理硕士学位。
- Syed T. Kamal is a co-founder of American Renal Associates Holdings, Inc. company and has served President and a director since American Renal Associates Holdings, Inc. inception in 1999. Mr. Kamal also served as Executive Vice President from 1999 to 2005. Mr. Kamal has nearly 40 years of experience in the dialysis services industry. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Kamal served in various management roles at Fresenius Medical Care North America "FMCNA", including as President of FMCNA's southern business unit, Vice President of Operations for FMCNA's North America division, Director and Vice President of Operations for FMNCA's International division and Regional Manager of FMNCA's Mid Atlantic and Southeast regions (U.S.). Mr. Kamal holds a B.A. in Economics and Statistics and an M.B.A. from the University of Punjab in Pakistan.
- Steven M. Silver
-
Steven M. Silver，他曾一直担任我们的董事会成员（2010年以来）。他也曾任职于Remedi SeniorCare Holding Corporation、Culligan Newco Ltd.、Frans Bonhomme SA、Reddy Ice Holdings公司、Senvion SE公司的董事会。他于2006年加入Centerbridge Partners公司，担任高级管理董事。加入Centerbridge Partners公司之前，他曾担任Vestar Capital Partners公司（一个私募股权投资公司）的董事总经理兼合伙人。任职Vestar公司之前，他负责多个行业（包括医疗保健服务和工业和制造业）私募股权投资的发起、谈判和融资，以及为各种投资组合公司提供正在进行的战略方向。他的职业生涯始于担任Wasserstein Perella & Co.（位于纽约和伦敦）的合并和收购部门的成员。他于1995年获得Yale College的学士学位、Harvard Business School的荣誉工商管理硕士学位，在那里他曾担任乔治贝克学者。
Steven M. Silver has served as a member of the Board since 2010. Mr. Silver also serves on the boards of directors of KIK Custom Products Inc., Wok Holdings, Ltd., Pei Wei Asian Diner LLC, Reddy Ice Holdings, Inc., Remedi SeniorCare Holding Corporation, TriMark USA, LLC and White Plains Hospital. Mr. Silver joined Centerbridge Partners, L.P. as a Senior Managing Director in 2006. Prior to joining Centerbridge Partners, L.P., Mr. Silver was a Managing Director and Partner at Vestar Capital Partners, a private equity investment firm. Mr. Silver began his career as a member of the Mergers & Acquisitions department of Wasserstein Perella & Co. in New York and London. Mr. Silver received a B.A. from Yale College and an M.B.A. with high distinction from Harvard Business School in 1995 where he was a George F. Baker Scholar. - Steven M. Silver，他曾一直担任我们的董事会成员（2010年以来）。他也曾任职于Remedi SeniorCare Holding Corporation、Culligan Newco Ltd.、Frans Bonhomme SA、Reddy Ice Holdings公司、Senvion SE公司的董事会。他于2006年加入Centerbridge Partners公司，担任高级管理董事。加入Centerbridge Partners公司之前，他曾担任Vestar Capital Partners公司（一个私募股权投资公司）的董事总经理兼合伙人。任职Vestar公司之前，他负责多个行业（包括医疗保健服务和工业和制造业）私募股权投资的发起、谈判和融资，以及为各种投资组合公司提供正在进行的战略方向。他的职业生涯始于担任Wasserstein Perella & Co.（位于纽约和伦敦）的合并和收购部门的成员。他于1995年获得Yale College的学士学位、Harvard Business School的荣誉工商管理硕士学位，在那里他曾担任乔治贝克学者。
- Steven M. Silver has served as a member of the Board since 2010. Mr. Silver also serves on the boards of directors of KIK Custom Products Inc., Wok Holdings, Ltd., Pei Wei Asian Diner LLC, Reddy Ice Holdings, Inc., Remedi SeniorCare Holding Corporation, TriMark USA, LLC and White Plains Hospital. Mr. Silver joined Centerbridge Partners, L.P. as a Senior Managing Director in 2006. Prior to joining Centerbridge Partners, L.P., Mr. Silver was a Managing Director and Partner at Vestar Capital Partners, a private equity investment firm. Mr. Silver began his career as a member of the Mergers & Acquisitions department of Wasserstein Perella & Co. in New York and London. Mr. Silver received a B.A. from Yale College and an M.B.A. with high distinction from Harvard Business School in 1995 where he was a George F. Baker Scholar.
- Jared S. Hendricks
-
Jared S. Hendricks，他担任我们的董事（2010年以来）。他也任职于IPC Corp.的董事会。他于2006年加入Centerbridge Partners公司，是现任高级董事总经理。加入Centerbridge Partners公司之前，他曾担任Silver Lake Partners公司（私人股本公司，专注于投资技术和相关公司经营规模增长）的律师（从2004年到2006年）。加入Silver Lake公司之前，他曾担任Credit Suisse First Boston公司的全球工业和服务集团的投资银行分析师。他于2004年以优异成绩获得宾夕法尼亚大学的沃顿商学院（the Wharton School of Finance at the University of Pennsylvania）的经济学学士学位。
Jared S. Hendricks has served as a member of the Board since 2010. Mr. Hendricks also serves on the boards of directors of IPC Corp., Ligado Networks LLC and Syncsort Incorporated. Mr. Hendricks joined Centerbridge Partners, L.P., an investment management firm employing a flexible approach across investment disciplines-from private equity to credit and related strategies, and real estate, in 2006 and has served as a Senior Managing Director since 2014. Prior to joining Centerbridge Partners, L.P., from 2004 to 2006 Mr. Hendricks was an Associate at Silver Lake Partners, a private equity firm focused on investments in technology and related growth companies. Prior to joining Silver Lake, he was an investment banking analyst within the Global Industrial and Services group at Credit Suisse First Boston. Mr. Hendricks graduated summa cum laude from The Wharton School of the University of Pennsylvania where he received a B.S. in Economics. - Jared S. Hendricks，他担任我们的董事（2010年以来）。他也任职于IPC Corp.的董事会。他于2006年加入Centerbridge Partners公司，是现任高级董事总经理。加入Centerbridge Partners公司之前，他曾担任Silver Lake Partners公司（私人股本公司，专注于投资技术和相关公司经营规模增长）的律师（从2004年到2006年）。加入Silver Lake公司之前，他曾担任Credit Suisse First Boston公司的全球工业和服务集团的投资银行分析师。他于2004年以优异成绩获得宾夕法尼亚大学的沃顿商学院（the Wharton School of Finance at the University of Pennsylvania）的经济学学士学位。
- Jared S. Hendricks has served as a member of the Board since 2010. Mr. Hendricks also serves on the boards of directors of IPC Corp., Ligado Networks LLC and Syncsort Incorporated. Mr. Hendricks joined Centerbridge Partners, L.P., an investment management firm employing a flexible approach across investment disciplines-from private equity to credit and related strategies, and real estate, in 2006 and has served as a Senior Managing Director since 2014. Prior to joining Centerbridge Partners, L.P., from 2004 to 2006 Mr. Hendricks was an Associate at Silver Lake Partners, a private equity firm focused on investments in technology and related growth companies. Prior to joining Silver Lake, he was an investment banking analyst within the Global Industrial and Services group at Credit Suisse First Boston. Mr. Hendricks graduated summa cum laude from The Wharton School of the University of Pennsylvania where he received a B.S. in Economics.
- Susanne V. Clark
-
SusanneV.Clark自2017年以来一直担任董事会成员。Clark女士自2009年以来担任Centerbridge Partners，L.P.的高级常务董事兼总法律顾问。在加入Centerbridge Partners，L.P.之前，Clark女士于2007年至2009年担任Basso Capital Management，L.P.的总法律顾问兼首席合规官，该公司是一家SEC注册的投资顾问，管理多策略，可转换债券和信贷基金。在Basso之前，Clark女士从2003年到2006年是Amaranth Group Inc.的副总法律顾问，这是一家多策略和多/空股票基金的投资顾问。在此之前，从1999年到2003年，克拉克曾担任高盛（Goldman Sachs）的Vice President和助理总法律顾问，负责涉及高盛集团的财务和公司法律事务，在此之前，她还负责涉及高盛投资银行业务的法律事务，Sachs&Co.Clark女士的职业生涯始于担任Shearman&Sterling LLP纽约办事处的助理。Clark女士还担任Kik Custom Products，Inc.的董事会成员。Clark女士以优异成绩毕业于斯沃斯莫尔学院（Swarthmore College），并在哥伦比亚法学院（Columbia Law School）获得法学博士学位。
Susanne V. Clark has served as a member of the Board since 2017. Ms. Clark has served as a Senior Managing Director and the General Counsel of Centerbridge Partners, L.P. since 2009. Prior to joining Centerbridge Partners, L.P., Ms. Clark was the General Counsel and Chief Compliance Officer of Basso Capital Management, L.P, an SEC-registered investment adviser managing multi-strategy, convertibles and credit funds from 2007 to 2009. Prior to Basso, Ms. Clark was the Deputy General Counsel of Amaranth Group Inc., an investment adviser for multi-strategy and long/short equity funds from 2003 to 2006. Before that, from 1999 to 2003 Ms. Clark served as Vice President and Assistant General Counsel at Goldman Sachs, where she was responsible for finance and corporate legal matters involving The Goldman Sachs Group, Inc. and, prior to that, for legal matters involving the investment banking business of Goldman, Sachs & Co. Ms. Clark started her career as an Associate in the New York office of Shearman & Sterling LLP. Ms. Clark also serves on the board of KIK Custom Products, Inc. Ms. Clark graduated with honors from Swarthmore College and received her J.D. from Columbia Law School. - SusanneV.Clark自2017年以来一直担任董事会成员。Clark女士自2009年以来担任Centerbridge Partners，L.P.的高级常务董事兼总法律顾问。在加入Centerbridge Partners，L.P.之前，Clark女士于2007年至2009年担任Basso Capital Management，L.P.的总法律顾问兼首席合规官，该公司是一家SEC注册的投资顾问，管理多策略，可转换债券和信贷基金。在Basso之前，Clark女士从2003年到2006年是Amaranth Group Inc.的副总法律顾问，这是一家多策略和多/空股票基金的投资顾问。在此之前，从1999年到2003年，克拉克曾担任高盛（Goldman Sachs）的Vice President和助理总法律顾问，负责涉及高盛集团的财务和公司法律事务，在此之前，她还负责涉及高盛投资银行业务的法律事务，Sachs&Co.Clark女士的职业生涯始于担任Shearman&Sterling LLP纽约办事处的助理。Clark女士还担任Kik Custom Products，Inc.的董事会成员。Clark女士以优异成绩毕业于斯沃斯莫尔学院（Swarthmore College），并在哥伦比亚法学院（Columbia Law School）获得法学博士学位。
- Susanne V. Clark has served as a member of the Board since 2017. Ms. Clark has served as a Senior Managing Director and the General Counsel of Centerbridge Partners, L.P. since 2009. Prior to joining Centerbridge Partners, L.P., Ms. Clark was the General Counsel and Chief Compliance Officer of Basso Capital Management, L.P, an SEC-registered investment adviser managing multi-strategy, convertibles and credit funds from 2007 to 2009. Prior to Basso, Ms. Clark was the Deputy General Counsel of Amaranth Group Inc., an investment adviser for multi-strategy and long/short equity funds from 2003 to 2006. Before that, from 1999 to 2003 Ms. Clark served as Vice President and Assistant General Counsel at Goldman Sachs, where she was responsible for finance and corporate legal matters involving The Goldman Sachs Group, Inc. and, prior to that, for legal matters involving the investment banking business of Goldman, Sachs & Co. Ms. Clark started her career as an Associate in the New York office of Shearman & Sterling LLP. Ms. Clark also serves on the board of KIK Custom Products, Inc. Ms. Clark graduated with honors from Swarthmore College and received her J.D. from Columbia Law School.
- Thomas W. Erickson
-
Thomas W. Erickson，自2004年5月以来，他成为董事会成员。从2002年9月起，他担任临时总裁和首席执行官直到2004年5月我们的聘任他。他目前是Western Dental Services, Inc.（一个牙科实务管理公司）和Inmar, Inc.（一个逆向物流和收入恢复公司）的董事会主席。之前，他担任Western Dental Services, Inc.的临时首席执行官、新山资本公司（New Mountain Capital, LLC是一个私募股权公司。）的高级顾问、国家医疗卫生卡系统公司（National Medical Health Card Systems, Inc.）的主席和临时总裁、PATHCare,Inc 。的药品福利经理和董事会主席、一个老人养护机构的运营者、TransHealthcare, Inc.公司（一个医疗保健服务公司）的董事会主席、LifeCare Holdings, Inc.的主席、临时总裁兼首席执行官、一个长期急症处理医院的运营者、欧米茄保健投资者公司（Omega Healthcare Investors, Inc.是一个医疗保健不动产投资信托公司。）的临时总裁、首席执行官兼董事。他也是CareSelect Group, Inc.（该公司是一个医生实务管理公司。）的联合创始人之一并担任总裁兼首席执行官。在他职业生涯的早期，他在美国医院供应公司（American Hospital Supply Corporation）担任一些管理职位。他目前在American Renal Holdings, Inc.（全国肾透析服务的供应商）的董事会任职。他获得爱荷华大学（University of Iowa）的学士学位和南卫理公会大学（Southern Methodist University）的工商管理硕士学位。
Thomas W. Erickson has served as a member of the Board since 2011. Mr. Erickson also serves as a member of the board of directors and chairman of the executive committee of Luminex Corporation, a Nasdaq-listed developer and manufacturer of biological testing technologies and products for the diagnostics, pharmaceutical and life sciences industries, as a member of the board of directors and chairman of the executive committee of 3D Systems Corporation, an NYSE-listed developer and manufacturer of 3D printing products and services, and as a senior advisor to Centerbridge Partners, L.P. Mr. Erickson has also held various public company directorships and executive roles, including chairman and interim chief executive officer of Western Dental Services, Inc., chairman of the board and interim chief executive officer of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of Pathways, Inc., an operator of post-acute care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim chief executive officer of LifeCare Health Partners, LLC, an operator of long-term acute care hospitals, interim president and chief executive officer of Luminex Corporation, interim president and chief executive officer of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust, and chairman of the board of Inmar, Inc., a reverse logistics and revenue recovery company. Mr. Erickson was also a cofounder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Earlier in his career, Mr. Erickson held several management positions at American Critical Care Corporation. Mr. Erickson holds a B.B.A. from the University of Iowa and an M.B.A. from Southern Methodist University. - Thomas W. Erickson，自2004年5月以来，他成为董事会成员。从2002年9月起，他担任临时总裁和首席执行官直到2004年5月我们的聘任他。他目前是Western Dental Services, Inc.（一个牙科实务管理公司）和Inmar, Inc.（一个逆向物流和收入恢复公司）的董事会主席。之前，他担任Western Dental Services, Inc.的临时首席执行官、新山资本公司（New Mountain Capital, LLC是一个私募股权公司。）的高级顾问、国家医疗卫生卡系统公司（National Medical Health Card Systems, Inc.）的主席和临时总裁、PATHCare,Inc 。的药品福利经理和董事会主席、一个老人养护机构的运营者、TransHealthcare, Inc.公司（一个医疗保健服务公司）的董事会主席、LifeCare Holdings, Inc.的主席、临时总裁兼首席执行官、一个长期急症处理医院的运营者、欧米茄保健投资者公司（Omega Healthcare Investors, Inc.是一个医疗保健不动产投资信托公司。）的临时总裁、首席执行官兼董事。他也是CareSelect Group, Inc.（该公司是一个医生实务管理公司。）的联合创始人之一并担任总裁兼首席执行官。在他职业生涯的早期，他在美国医院供应公司（American Hospital Supply Corporation）担任一些管理职位。他目前在American Renal Holdings, Inc.（全国肾透析服务的供应商）的董事会任职。他获得爱荷华大学（University of Iowa）的学士学位和南卫理公会大学（Southern Methodist University）的工商管理硕士学位。
- Thomas W. Erickson has served as a member of the Board since 2011. Mr. Erickson also serves as a member of the board of directors and chairman of the executive committee of Luminex Corporation, a Nasdaq-listed developer and manufacturer of biological testing technologies and products for the diagnostics, pharmaceutical and life sciences industries, as a member of the board of directors and chairman of the executive committee of 3D Systems Corporation, an NYSE-listed developer and manufacturer of 3D printing products and services, and as a senior advisor to Centerbridge Partners, L.P. Mr. Erickson has also held various public company directorships and executive roles, including chairman and interim chief executive officer of Western Dental Services, Inc., chairman of the board and interim chief executive officer of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of Pathways, Inc., an operator of post-acute care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim chief executive officer of LifeCare Health Partners, LLC, an operator of long-term acute care hospitals, interim president and chief executive officer of Luminex Corporation, interim president and chief executive officer of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust, and chairman of the board of Inmar, Inc., a reverse logistics and revenue recovery company. Mr. Erickson was also a cofounder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Earlier in his career, Mr. Erickson held several management positions at American Critical Care Corporation. Mr. Erickson holds a B.B.A. from the University of Iowa and an M.B.A. from Southern Methodist University.
- Michael E. Boxer
-
Michael E. Boxer，2006年4月起担任本公司董事。他从2008年7月起，担任The Enterprise Group的总裁，这是医疗保健行业的财务顾问公司。2010年5月起，他担任American Renal Holdings的董事，这是肾透析服务的全国性供应商。他还从2011年9月起，担任Remedi SeniorCare Holding Corporation的董事，这是一个公共机构药物供应商。之前，2006年9月至2008年6月，他担任HealthMarkets的首席财务官，该公司为个人和小型团体提供健康及生命的保险产品。2005年3月至2006年9月，他是 The Enterprise Group的总裁。2003年1月起，他担任Mariner Health Care的执行副总裁、首席财务官，直到2004年12月它被出售，该公司提供熟练的护理与长期医疗保健服务。1998年7月至2002年12月，他担任Watson Pharmaceuticals的高级副总裁、首席财务官，这是纽交所上市的专业制药公司。加入Watson之前，他是Furman Selz, LLC的一名投资银行家，这是位于纽约的投资银行。
Michael E. Boxer has served as a member of the Board since 2010. Mr. Boxer is President of The Enterprise Group Ltd., a healthcare advisory firm. Previously, he served as a senior advisor to Centerbridge Partners, L.P. from 2011 to 2018. Mr. Boxer serves on the board of directors of GI Scientific and Clever Care Health Plan, Inc. Mr. Boxer previously served as vice chairperson of the board of directors and as chairperson of the audit and compliance committees of Remedi SeniorCare Holding Corporation and served on the board of directors and was chairperson of the audit committee and compliance committees of Versant Health formerly Superior Vision Corporation. He served as chairperson of the audit committee and as a board member of Genesis Healthcare, Inc. (formerly Skilled Healthcare Group, Inc.) from 2006 until 2015. Mr. Boxer served as the chief financial officer of HealthMarkets, Inc., a provider of health and life insurance products. Mr. Boxer was chief financial officer of Mariner Health Care, Inc., a skilled nursing facility and long-term acute care provider. Mr. Boxer served as chief financial officer of Allergan plc (formerly Watson Pharmaceuticals Inc.), an integrated specialty pharmaceutical company. Prior to that, Mr. Boxer was a healthcare investment banker at Furman Selz. Mr. Boxer received a B.B.A. in Finance from Colorado State University and an M.B.A. from the University of Chicago Booth School of Business. - Michael E. Boxer，2006年4月起担任本公司董事。他从2008年7月起，担任The Enterprise Group的总裁，这是医疗保健行业的财务顾问公司。2010年5月起，他担任American Renal Holdings的董事，这是肾透析服务的全国性供应商。他还从2011年9月起，担任Remedi SeniorCare Holding Corporation的董事，这是一个公共机构药物供应商。之前，2006年9月至2008年6月，他担任HealthMarkets的首席财务官，该公司为个人和小型团体提供健康及生命的保险产品。2005年3月至2006年9月，他是 The Enterprise Group的总裁。2003年1月起，他担任Mariner Health Care的执行副总裁、首席财务官，直到2004年12月它被出售，该公司提供熟练的护理与长期医疗保健服务。1998年7月至2002年12月，他担任Watson Pharmaceuticals的高级副总裁、首席财务官，这是纽交所上市的专业制药公司。加入Watson之前，他是Furman Selz, LLC的一名投资银行家，这是位于纽约的投资银行。
- Michael E. Boxer has served as a member of the Board since 2010. Mr. Boxer is President of The Enterprise Group Ltd., a healthcare advisory firm. Previously, he served as a senior advisor to Centerbridge Partners, L.P. from 2011 to 2018. Mr. Boxer serves on the board of directors of GI Scientific and Clever Care Health Plan, Inc. Mr. Boxer previously served as vice chairperson of the board of directors and as chairperson of the audit and compliance committees of Remedi SeniorCare Holding Corporation and served on the board of directors and was chairperson of the audit committee and compliance committees of Versant Health formerly Superior Vision Corporation. He served as chairperson of the audit committee and as a board member of Genesis Healthcare, Inc. (formerly Skilled Healthcare Group, Inc.) from 2006 until 2015. Mr. Boxer served as the chief financial officer of HealthMarkets, Inc., a provider of health and life insurance products. Mr. Boxer was chief financial officer of Mariner Health Care, Inc., a skilled nursing facility and long-term acute care provider. Mr. Boxer served as chief financial officer of Allergan plc (formerly Watson Pharmaceuticals Inc.), an integrated specialty pharmaceutical company. Prior to that, Mr. Boxer was a healthcare investment banker at Furman Selz. Mr. Boxer received a B.B.A. in Finance from Colorado State University and an M.B.A. from the University of Chicago Booth School of Business.
- John M. Jureller
-
John M. Jureller，2013年1月，他担任 Frontier执行副总裁和首席财务官，2013年2月27日当选首席财务官。自2008年4月至2012年10月，他担任高级副总裁，负责通用大西洋资源组财务及营运。从2006年3月至2008年3月，他是西点国际公司首席财务官。从2003年4月到2006年2月，他是AlixPartners公司的一员。在加入AlixPartners公司之前，他是跨资源公司的首席财务官、高级副总裁，负责Gartner公司的发展；嘉略国际公司的高级副总裁，负责嘉略国际公司财务与公司发展。
John M. Jureller has served as a member of the Board since 2015. Mr. Jureller also serves on the board of directors of White Plains Hospital in White Plains, New York and is the Chairman of the finance committee of White Plains Hospital. Mr. Jureller served on the audit committees of Studio Moderna Holdings B.V. from 2011 to 2012 and Torex Retail Holdings Ltd. from 2009 to 2012. Since March 2020 Mr. Jureller has served as Chief Financial Officer of Knotel, Inc., a flexible workspace provider. From 2017 to February 2020 Mr. Jureller served as a Managing Director at Accordion Partners, a financial advisory firm. Mr. Jureller was an independent financial and management consultant from 2016 to 2017 and prior to that served as the Executive Vice President and Chief Financial Officer of Frontier Communications Corp. from 2013 until 2016. Prior to joining Frontier Communications Corp., Mr. Jureller served in a variety of senior financial roles with various companies including General Atlantic LLC, WestPoint International, Inc., AlixPartners, LLP, PepsiCo, Inc. and General Electric Capital Corporation. Mr. Jureller began his career with the corporate banking and leveraged finance groups at Bankers Trust Company. Mr. Jureller received a B.S. in Finance and an M.B.A. from Cornell University. - John M. Jureller，2013年1月，他担任 Frontier执行副总裁和首席财务官，2013年2月27日当选首席财务官。自2008年4月至2012年10月，他担任高级副总裁，负责通用大西洋资源组财务及营运。从2006年3月至2008年3月，他是西点国际公司首席财务官。从2003年4月到2006年2月，他是AlixPartners公司的一员。在加入AlixPartners公司之前，他是跨资源公司的首席财务官、高级副总裁，负责Gartner公司的发展；嘉略国际公司的高级副总裁，负责嘉略国际公司财务与公司发展。
- John M. Jureller has served as a member of the Board since 2015. Mr. Jureller also serves on the board of directors of White Plains Hospital in White Plains, New York and is the Chairman of the finance committee of White Plains Hospital. Mr. Jureller served on the audit committees of Studio Moderna Holdings B.V. from 2011 to 2012 and Torex Retail Holdings Ltd. from 2009 to 2012. Since March 2020 Mr. Jureller has served as Chief Financial Officer of Knotel, Inc., a flexible workspace provider. From 2017 to February 2020 Mr. Jureller served as a Managing Director at Accordion Partners, a financial advisory firm. Mr. Jureller was an independent financial and management consultant from 2016 to 2017 and prior to that served as the Executive Vice President and Chief Financial Officer of Frontier Communications Corp. from 2013 until 2016. Prior to joining Frontier Communications Corp., Mr. Jureller served in a variety of senior financial roles with various companies including General Atlantic LLC, WestPoint International, Inc., AlixPartners, LLP, PepsiCo, Inc. and General Electric Capital Corporation. Mr. Jureller began his career with the corporate banking and leveraged finance groups at Bankers Trust Company. Mr. Jureller received a B.S. in Finance and an M.B.A. from Cornell University.
- Robert H. Fish
-
Robert H. Fish，2013年11年起担任本公司董事；当时，他刚加入本公司，担任首席执行官。整个职业生涯中，他在多个医疗保健公司中担任过董事长、总裁、首席执行官。2012年到2013年加入本公司期间，他是Sonoma-Seacrest, LLC的管理合伙人，这是加利福尼亚的一家医疗保健行业公司，专门从事战略规划、绩效改进、并购方面的事务。2008-2012，他担任REACH Medical Holdings的董事长，这是一家地区性的空中医疗运输公司；2005-2006，担任Coram的执行董事长，这是大型的家用输液供应商；2002-2004，担任Genesis Health Ventures的董事长、首席执行官，这是一个长期护理与公共机构药物公司。他从2013年起，担任St. Helena Hospital Foundation的董事，这是位于北加州的非营利机构。他还曾担任St. Joseph Health System - Sonoma County 和 Valleycare Health System的总裁、首席执行官，上述两机构都是位于北加州的区域性医院系统。
Robert H. Fish has served as a member of the Board since 2017. Mr. Fish has served, since May 2018 as Chief Executive Officer and, since September 2018 as a member of the board of directors of Quorum Health Corporation, an operator of general acute care hospitals and outpatient services. Prior to joining Quorum Health, he served as Interim Chief Executive Officer of Millennium Health, LLC from January 2018 to March 2018. Mr. Fish also serves as the Chairman of the board of directors of Genesis Healthcare, Inc., a national provider of post-acute healthcare services “Genesis”. Mr. Fish joined Skilled Healthcare Group, Inc., which was later acquired by Genesis, as the Chief Executive Officer in 2013. Mr. Fish served as Skilled Healthcare’s Chief Executive Officer until February 2015 when the combination of Skilled Healthcare and Genesis was completed. During his career, Mr. Fish has served as Chairman, President or Chief Executive Officer of a number of public and private healthcare services companies. From 2012 until he joined Skilled Healthcare in 2013 Mr. Fish served as Managing Partner of Sonoma-Seacrest, LLC, a California health care firm specializing in strategic planning, performance improvement and merger and acquisition matters. Mr. Fish’s prior board positions include serving as the Chairman of REACH Medical Holdings, a regional air medical transport company, from 2008 to 2012 which was acquired by Air Medical Group Holdings; serving as the Executive Chairman of Coram, Inc., a large home infusion provider, from 2005 to 2006 until its sale to Apria; serving as a director of NeighborCare, Inc., a large institutional pharmacy, from 2003 to 2005 until its acquisition by Omnicare; and serving as the Lead Director of Genesis from 2003 to 2007. From 2001 to 2002 Mr. Fish served as a director and subsequently from 2002 to 2003 Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures, a long-term care and institutional pharmacy company and predecessor in interest to Genesis. Mr. Fish also has extensive experience in hospital administration, having been President and Chief Executive Officer of St. Joseph Health System from 1995 to 1999 and Valley Care Health System from 1985 to 1995 as well as a member of the Board of Directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley, since 2013. Mr. Fish received a B.A. degree in Sociology from Whittier College and a M.P.H. degree in Hospital Administration from the University of California, Berkeley. - Robert H. Fish，2013年11年起担任本公司董事；当时，他刚加入本公司，担任首席执行官。整个职业生涯中，他在多个医疗保健公司中担任过董事长、总裁、首席执行官。2012年到2013年加入本公司期间，他是Sonoma-Seacrest, LLC的管理合伙人，这是加利福尼亚的一家医疗保健行业公司，专门从事战略规划、绩效改进、并购方面的事务。2008-2012，他担任REACH Medical Holdings的董事长，这是一家地区性的空中医疗运输公司；2005-2006，担任Coram的执行董事长，这是大型的家用输液供应商；2002-2004，担任Genesis Health Ventures的董事长、首席执行官，这是一个长期护理与公共机构药物公司。他从2013年起，担任St. Helena Hospital Foundation的董事，这是位于北加州的非营利机构。他还曾担任St. Joseph Health System - Sonoma County 和 Valleycare Health System的总裁、首席执行官，上述两机构都是位于北加州的区域性医院系统。
- Robert H. Fish has served as a member of the Board since 2017. Mr. Fish has served, since May 2018 as Chief Executive Officer and, since September 2018 as a member of the board of directors of Quorum Health Corporation, an operator of general acute care hospitals and outpatient services. Prior to joining Quorum Health, he served as Interim Chief Executive Officer of Millennium Health, LLC from January 2018 to March 2018. Mr. Fish also serves as the Chairman of the board of directors of Genesis Healthcare, Inc., a national provider of post-acute healthcare services “Genesis”. Mr. Fish joined Skilled Healthcare Group, Inc., which was later acquired by Genesis, as the Chief Executive Officer in 2013. Mr. Fish served as Skilled Healthcare’s Chief Executive Officer until February 2015 when the combination of Skilled Healthcare and Genesis was completed. During his career, Mr. Fish has served as Chairman, President or Chief Executive Officer of a number of public and private healthcare services companies. From 2012 until he joined Skilled Healthcare in 2013 Mr. Fish served as Managing Partner of Sonoma-Seacrest, LLC, a California health care firm specializing in strategic planning, performance improvement and merger and acquisition matters. Mr. Fish’s prior board positions include serving as the Chairman of REACH Medical Holdings, a regional air medical transport company, from 2008 to 2012 which was acquired by Air Medical Group Holdings; serving as the Executive Chairman of Coram, Inc., a large home infusion provider, from 2005 to 2006 until its sale to Apria; serving as a director of NeighborCare, Inc., a large institutional pharmacy, from 2003 to 2005 until its acquisition by Omnicare; and serving as the Lead Director of Genesis from 2003 to 2007. From 2001 to 2002 Mr. Fish served as a director and subsequently from 2002 to 2003 Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures, a long-term care and institutional pharmacy company and predecessor in interest to Genesis. Mr. Fish also has extensive experience in hospital administration, having been President and Chief Executive Officer of St. Joseph Health System from 1995 to 1999 and Valley Care Health System from 1985 to 1995 as well as a member of the Board of Directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley, since 2013. Mr. Fish received a B.A. degree in Sociology from Whittier College and a M.P.H. degree in Hospital Administration from the University of California, Berkeley.
高管简历
中英对照 | 中文 | 英文- Joseph A. Carlucci
Joseph A. Carlucci是American Renal Associates Holdings, Inc.的联合创始人，自2005年起担任首席执行官，并自2012年起担任Shlomo Kramer。Carlucci先生在透析服务行业拥有40多年的经验。Carlucci先生还在American Renal Associates Holdings, Inc.于1999年至2005年成立期间担任American Renal Associates Holdings, Inc.的首席运营官和财务主管。在共同创立American Renal Associates Holdings, Inc.之前，Carlucci先生曾担任Optimal Renal Care的总裁兼首席执行官，Optimal Renal Care是FMCNA和南加州Kaiser Permanente的合资企业，旨在作为一家疾病管理组织，提供更多机会来改善治疗效果，改善成本结构并实施透析护理的新技术和方法。在此之前，Carlucci先生曾担任FMCNA的行政副总裁，负责全国范围内的管理式护理、医疗总监关系和设施开发。他拥有从设施管理员到FMCNA美国运营总监的运营经验。Carlucci先生还在科罗拉多生殖医学中心的董事会任职。Carlucci先生拥有学士学位，本特利大学会计学博士。
Joseph A. Carlucci is a co-founder of American Renal Associates Holdings, Inc. and has served as Chief Executive Officer since 2005 and as Chairman of the Board since 2012. Mr. Carlucci has more than 40 years of experience in the dialysis services industry. Mr. Carlucci also served as American Renal Associates Holdings, Inc. Chief Operating Officer and Treasurer from American Renal Associates Holdings, Inc. inception in 1999 to 2005. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Carlucci served as President and Chief Executive Officer of Optimal Renal Care, a joint venture between FMCNA and Kaiser Permanente of Southern California designed as a disease management organization providing additional opportunities to improve treatment outcomes, improve cost structures and implement new technologies and methods of dialysis care. Prior to that, Mr. Carlucci served as Vice President of Administration at FMCNA and was responsible nationally for managed care, medical director relations and facility development. He has operations experience from Facility Administrator to Director of U.S. Operations at FMCNA. Mr. Carlucci also serves on the board of directors of the Colorado Center for Reproductive Medicine. Mr. Carlucci holds a B.S. in Accounting from Bentley University.- Joseph A. Carlucci是American Renal Associates Holdings, Inc.的联合创始人，自2005年起担任首席执行官，并自2012年起担任Shlomo Kramer。Carlucci先生在透析服务行业拥有40多年的经验。Carlucci先生还在American Renal Associates Holdings, Inc.于1999年至2005年成立期间担任American Renal Associates Holdings, Inc.的首席运营官和财务主管。在共同创立American Renal Associates Holdings, Inc.之前，Carlucci先生曾担任Optimal Renal Care的总裁兼首席执行官，Optimal Renal Care是FMCNA和南加州Kaiser Permanente的合资企业，旨在作为一家疾病管理组织，提供更多机会来改善治疗效果，改善成本结构并实施透析护理的新技术和方法。在此之前，Carlucci先生曾担任FMCNA的行政副总裁，负责全国范围内的管理式护理、医疗总监关系和设施开发。他拥有从设施管理员到FMCNA美国运营总监的运营经验。Carlucci先生还在科罗拉多生殖医学中心的董事会任职。Carlucci先生拥有学士学位，本特利大学会计学博士。
- Joseph A. Carlucci is a co-founder of American Renal Associates Holdings, Inc. and has served as Chief Executive Officer since 2005 and as Chairman of the Board since 2012. Mr. Carlucci has more than 40 years of experience in the dialysis services industry. Mr. Carlucci also served as American Renal Associates Holdings, Inc. Chief Operating Officer and Treasurer from American Renal Associates Holdings, Inc. inception in 1999 to 2005. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Carlucci served as President and Chief Executive Officer of Optimal Renal Care, a joint venture between FMCNA and Kaiser Permanente of Southern California designed as a disease management organization providing additional opportunities to improve treatment outcomes, improve cost structures and implement new technologies and methods of dialysis care. Prior to that, Mr. Carlucci served as Vice President of Administration at FMCNA and was responsible nationally for managed care, medical director relations and facility development. He has operations experience from Facility Administrator to Director of U.S. Operations at FMCNA. Mr. Carlucci also serves on the board of directors of the Colorado Center for Reproductive Medicine. Mr. Carlucci holds a B.S. in Accounting from Bentley University.
- Syed T. Kamal
Syed T. Kamal是American Renal联合控股公司的联合创始人，自1999年American Renal联合控股公司成立以来一直担任总裁和董事。Kamal先生还在1999年至2005年期间担任执行副总裁。Kamal先生在透析服务行业拥有近40年的经验。在共同创立American Renal Associates Holdings, Inc.之前，Kamal先生曾在费森尤斯医疗北美“FMCNA”担任过各种管理职务，包括FMCNA南部业务部总裁、FMCNA北美分部运营副总裁、FMNCA国际部运营总监兼副总裁，FMNCA中大西洋和东南部地区（美国）区域经理。Kamal先生拥有学士学位。巴基斯坦旁遮普大学经济学和统计学学士以及工商管理硕士学位。
Syed T. Kamal is a co-founder of American Renal Associates Holdings, Inc. company and has served President and a director since American Renal Associates Holdings, Inc. inception in 1999. Mr. Kamal also served as Executive Vice President from 1999 to 2005. Mr. Kamal has nearly 40 years of experience in the dialysis services industry. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Kamal served in various management roles at Fresenius Medical Care North America "FMCNA", including as President of FMCNA's southern business unit, Vice President of Operations for FMCNA's North America division, Director and Vice President of Operations for FMNCA's International division and Regional Manager of FMNCA's Mid Atlantic and Southeast regions (U.S.). Mr. Kamal holds a B.A. in Economics and Statistics and an M.B.A. from the University of Punjab in Pakistan.- Syed T. Kamal是American Renal联合控股公司的联合创始人，自1999年American Renal联合控股公司成立以来一直担任总裁和董事。Kamal先生还在1999年至2005年期间担任执行副总裁。Kamal先生在透析服务行业拥有近40年的经验。在共同创立American Renal Associates Holdings, Inc.之前，Kamal先生曾在费森尤斯医疗北美“FMCNA”担任过各种管理职务，包括FMCNA南部业务部总裁、FMCNA北美分部运营副总裁、FMNCA国际部运营总监兼副总裁，FMNCA中大西洋和东南部地区（美国）区域经理。Kamal先生拥有学士学位。巴基斯坦旁遮普大学经济学和统计学学士以及工商管理硕士学位。
- Syed T. Kamal is a co-founder of American Renal Associates Holdings, Inc. company and has served President and a director since American Renal Associates Holdings, Inc. inception in 1999. Mr. Kamal also served as Executive Vice President from 1999 to 2005. Mr. Kamal has nearly 40 years of experience in the dialysis services industry. Prior to co-founding American Renal Associates Holdings, Inc., Mr. Kamal served in various management roles at Fresenius Medical Care North America "FMCNA", including as President of FMCNA's southern business unit, Vice President of Operations for FMCNA's North America division, Director and Vice President of Operations for FMNCA's International division and Regional Manager of FMNCA's Mid Atlantic and Southeast regions (U.S.). Mr. Kamal holds a B.A. in Economics and Statistics and an M.B.A. from the University of Punjab in Pakistan.
- Don E. Williamson
Don E.Williamson是我们的执行Vice President和首席运营官。在2017年被任命为首席运营官之前，Williamson博士自2011年起担任我们的三名国家首席医疗官之一，自2002年起担任我们的肾病学家合作伙伴之一。他拥有超过25年的肾脏学家经验。在被任命为首席运营官之前，他于1998年至2017年担任我们在乔治亚州奥古斯塔的诊所合资企业Nephrology Associates，P.C.的总裁，首席执行官和管理合伙人，并担任我们诊所合资企业的创始人兼首席执行官，2001年至2017年，美国肾脏学中心有限责任公司。他是Kinetic Decision Solutions LLC（电子病历软件开发商）的联合创始人，并自2010年起担任其首席执行官和管理合伙人。Williamson博士在默瑟大学（Mercer University）获得化学学士学位，并在乔治亚医学院（Medical College of Georgia）获得医学博士学位。
Don E. Williamson is our Executive Vice President and Chief Operating Officer. Prior to being appointed Chief Operating Officer in 2017 Dr. Williamson served as one of our three national Chief Medical Officers since 2011 and as one of our nephrologist partners since 2002. He has more than 25 years of experience as a nephrologist. Prior to his appointment as Chief Operating Officer, he served as President, Chief Executive Officer and Managing Partner for our clinic joint venture Nephrology Associates, P.C. in Augusta, Georgia from 1998 to 2017 and as the Founder and Chief Executive Officer of our clinic joint venture, Nephrology Centers of America, LLC, from 2001 to 2017. He is the Co-Founder and, since 2010 has been the Chief Executive Officer and Managing Partner of Kinetic Decision Solutions LLC, a developer of electronic medical record software. Dr. Williamson received his B.A. in Chemistry from Mercer University and his M.D. from the Medical College of Georgia.- Don E.Williamson是我们的执行Vice President和首席运营官。在2017年被任命为首席运营官之前，Williamson博士自2011年起担任我们的三名国家首席医疗官之一，自2002年起担任我们的肾病学家合作伙伴之一。他拥有超过25年的肾脏学家经验。在被任命为首席运营官之前，他于1998年至2017年担任我们在乔治亚州奥古斯塔的诊所合资企业Nephrology Associates，P.C.的总裁，首席执行官和管理合伙人，并担任我们诊所合资企业的创始人兼首席执行官，2001年至2017年，美国肾脏学中心有限责任公司。他是Kinetic Decision Solutions LLC（电子病历软件开发商）的联合创始人，并自2010年起担任其首席执行官和管理合伙人。Williamson博士在默瑟大学（Mercer University）获得化学学士学位，并在乔治亚医学院（Medical College of Georgia）获得医学博士学位。
- Don E. Williamson is our Executive Vice President and Chief Operating Officer. Prior to being appointed Chief Operating Officer in 2017 Dr. Williamson served as one of our three national Chief Medical Officers since 2011 and as one of our nephrologist partners since 2002. He has more than 25 years of experience as a nephrologist. Prior to his appointment as Chief Operating Officer, he served as President, Chief Executive Officer and Managing Partner for our clinic joint venture Nephrology Associates, P.C. in Augusta, Georgia from 1998 to 2017 and as the Founder and Chief Executive Officer of our clinic joint venture, Nephrology Centers of America, LLC, from 2001 to 2017. He is the Co-Founder and, since 2010 has been the Chief Executive Officer and Managing Partner of Kinetic Decision Solutions LLC, a developer of electronic medical record software. Dr. Williamson received his B.A. in Chemistry from Mercer University and his M.D. from the Medical College of Georgia.
- Mark C. Herbers
Mark C.Herbers自2019年3月起担任我们的临时首席财务官兼临时首席会计官。他目前受聘于AP Services，LLC“；APS”；（一家咨询公司），担任财务咨询服务实践的董事（2014年以来）。Herbers先生为各种梦百合提供者和保健系统提供财务领导和管理。他的专业知识包括改善收入周期表现、解决监管、报销、融资和战略规划事项和医生关系。加入APS公司之前，他曾任职FTI Consulting公司及其前身Cambio Health Solutions公司（从2004年到2014年），最终担任董事总经理。Herbers先生还从2002年到2003年担任Progressive Financial Services的总裁，负责风险咨询服务，1999年至2002年在毕马威会计师事务所担任梦百合，1997年至1999年在哥伦比亚拉格朗日纪念医院担任首席财务官，1997年至1998年担任家庭保健首席运营官和首席财务官，1993年至1996年在银十字医院担任首席财务官。在此之前，Herbers先生曾担任多个其他财务和会计职位。Herbers先生在乔治敦大学（Georgetown University）获得文学学士学位，在圣路易斯（St.Louis）的华盛顿大学（Washington University）获得工商管理硕士学位。
Mark C. Herbers has served as our Interim Chief Financial Officer and Interim Chief Accounting Officer since March 2019. He is currently employed as a Director with AP Services, LLC “APS”, a consulting firm, in the Financial Advisory Services practice, where he has been employed since 2014. Mr. Herbers has provided financial leadership and management to various healthcare providers and health systems. His expertise includes improving revenue cycle performance, addressing regulatory, reimbursement, financing and strategic planning matters and physician relations. Prior to joining APS, he served at FTI Consulting and its predecessor Cambio Health Solutions from 2004 to 2014 ultimately serving as Managing Director. Mr. Herbers has also served as President at Progressive Financial Services from 2002-2003 Director in Risk Advisory Services, Healthcare at KPMG from 1999-2002 Chief Financial Officer at Columbia LaGrange Memorial Hospital from 1997-1999 Chief Operating Officer and Chief Financial Officer at In Home Health Care from 1997-1998 and Chief Financial Officer at Silver Cross Hospital from 1993-1996. Prior to that time, Mr. Herbers held a number of other finance and accounting positions. Mr. Herbers received a B.A from Georgetown University and an M.B.A. from Washington University in St. Louis.- Mark C.Herbers自2019年3月起担任我们的临时首席财务官兼临时首席会计官。他目前受聘于AP Services，LLC“；APS”；（一家咨询公司），担任财务咨询服务实践的董事（2014年以来）。Herbers先生为各种梦百合提供者和保健系统提供财务领导和管理。他的专业知识包括改善收入周期表现、解决监管、报销、融资和战略规划事项和医生关系。加入APS公司之前，他曾任职FTI Consulting公司及其前身Cambio Health Solutions公司（从2004年到2014年），最终担任董事总经理。Herbers先生还从2002年到2003年担任Progressive Financial Services的总裁，负责风险咨询服务，1999年至2002年在毕马威会计师事务所担任梦百合，1997年至1999年在哥伦比亚拉格朗日纪念医院担任首席财务官，1997年至1998年担任家庭保健首席运营官和首席财务官，1993年至1996年在银十字医院担任首席财务官。在此之前，Herbers先生曾担任多个其他财务和会计职位。Herbers先生在乔治敦大学（Georgetown University）获得文学学士学位，在圣路易斯（St.Louis）的华盛顿大学（Washington University）获得工商管理硕士学位。
- Mark C. Herbers has served as our Interim Chief Financial Officer and Interim Chief Accounting Officer since March 2019. He is currently employed as a Director with AP Services, LLC “APS”, a consulting firm, in the Financial Advisory Services practice, where he has been employed since 2014. Mr. Herbers has provided financial leadership and management to various healthcare providers and health systems. His expertise includes improving revenue cycle performance, addressing regulatory, reimbursement, financing and strategic planning matters and physician relations. Prior to joining APS, he served at FTI Consulting and its predecessor Cambio Health Solutions from 2004 to 2014 ultimately serving as Managing Director. Mr. Herbers has also served as President at Progressive Financial Services from 2002-2003 Director in Risk Advisory Services, Healthcare at KPMG from 1999-2002 Chief Financial Officer at Columbia LaGrange Memorial Hospital from 1997-1999 Chief Operating Officer and Chief Financial Officer at In Home Health Care from 1997-1998 and Chief Financial Officer at Silver Cross Hospital from 1993-1996. Prior to that time, Mr. Herbers held a number of other finance and accounting positions. Mr. Herbers received a B.A from Georgetown University and an M.B.A. from Washington University in St. Louis.